Lorecivivint Uses, Dosage, Side Effects and more
Lorecivivint is under investigation in clinical trial NCT03246399 (A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease).
| Attribute | Details |
|---|---|
| Trade Name | Lorecivivint |
| Generic | Lorecivivint |
| Lorecivivint Other Names | Lorecivivint |
| Type | |
| Formula | C29H24FN7O |
| Weight | Average: 505.557 Monoisotopic: 505.202636584 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
